Optomed Oyj reported earnings results for the fourth quarter and full year ended December 31, 2022. For the fourth quarter, the company reported sales was EUR 4.01 million compared to EUR 3.55 million a year ago. Net loss was EUR 1.4 million compared to EUR 1.94 million a year ago. Basic loss per share from continuing operations was EUR 0.1 compared to EUR 0.14 a year ago.
For the full year, sales was EUR 14.66 million compared to EUR 14.85 million a year ago. Net loss was EUR 5.47 million compared to EUR 4.25 million a year ago. Basic loss per share from continuing operations was EUR 0.37 compared to EUR 0.32 a year ago.